Matrine improves 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice

被引:66
作者
Cheng, H
Xia, B
Zhang, L
Zhou, F
Zhang, YX
Ye, M
Hu, ZG
Li, J
Li, J
Wang, ZL
Li, C
Guo, QS
机构
[1] Wuhan Univ, Sch Med, Zhongnan Hosp, Dept Internal Med & Genet, Wuhan, Peoples R China
[2] Wuhan Univ, Sch Med, Key Lab Allergy & Immune Related Dis, Wuhan 430071, Peoples R China
关键词
matrine; trinitrobenzene sulfonic acid; colitis; mice; tumour necrosis factor-alpha;
D O I
10.1016/j.phrs.2005.11.001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Matrine is an alkaloid found in kinds of Sophora plants mainly including Sophora flavescens, Sophora alopecuroides and Sophora subprotrata. The aim of the present study was to evaluate therapeutic effects of matrine on 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis in mice. Two hours following colonic instillation of TNBS, matrine with several doses was given by gastric gavage once daily for 7 days. Comparing with the 0.9% NaCl-treated mice with TNBS-induced colitis, matrine (10 and 20 mg kg(-1))-treated mice with TNBS-induced colitis were shown improvements of weight loss, macroscopic score, histological score, and myeloperoxidase (MPO) activity. Moreover, treatments with matrine (10 and 20 mg kg(-1)) decreased the up-regulated mRNA and protein levels of tumour necrosis factor-alpha (TNF-alpha) caused by TNBS. Our findings suggest that matrine improves TNBS-induced colitis in mice and the therapeutic mechanism might be related to the reduction of up-regulated colonic TNF-alpha production caused by TNBS. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:202 / 208
页数:7
相关论文
共 35 条
[1]   What next after infliximab? [J].
Baidoo, L ;
Lichtenstein, GR .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (01) :80-83
[2]   MEASUREMENT OF CUTANEOUS INFLAMMATION - ESTIMATION OF NEUTROPHIL CONTENT WITH AN ENZYME MARKER [J].
BRADLEY, PP ;
PRIEBAT, DA ;
CHRISTENSEN, RD ;
ROTHSTEIN, G .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1982, 78 (03) :206-209
[3]   MYELOPEROXIDASE AND INTESTINAL INFLAMMATION [J].
CASTRO, GA .
GASTROENTEROLOGY, 1985, 88 (05) :1294-1295
[4]  
CHANG MS, 1991, ACTA PHARM SINIC, V12, P121
[5]   Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial [J].
D'Haens, G ;
Van Deventer, S ;
Van Hogezand, R ;
Chalmers, D ;
Kothe, C ;
Baert, F ;
Braakman, T ;
Schaible, T ;
Geboes, K ;
Rutgeerts, P .
GASTROENTEROLOGY, 1999, 116 (05) :1029-1034
[6]  
Deng Hui, 2004, Zhong Yao Cai, V27, P416
[7]   Inflammatory bowel disease: Etiology and pathogenesis [J].
Fiocchi, C .
GASTROENTEROLOGY, 1998, 115 (01) :182-205
[8]   Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice [J].
Fuss, IJ ;
Marth, T ;
Neurath, MF ;
Pearlstein, GR ;
Jain, A ;
Strober, W .
GASTROENTEROLOGY, 1999, 117 (05) :1078-1088
[9]   Involvement of neutrophils and free radicals in the potentiating effects of passive cigarette smoking on inflammatory bowel disease in rats [J].
Guo, X ;
Wang, WP ;
Ko, JKS ;
Cho, CH .
GASTROENTEROLOGY, 1999, 117 (04) :884-892
[10]  
Hu ZL, 1996, ACTA PHARMACOL SIN, V17, P259